AngioDynamics beat on sales and beat on earnings this morning -- sort of. The company reported a smaller-than-expected ...

A Capital Region manufacturer expects to continue growing its revenue over the next year, though its bottom line could take a ...

Q4 2025 Earnings Call Transcript July 15, 2025 AngioDynamics, Inc. beats earnings expectations. Reported EPS is $-0.03, expectations were $-0.13. Operator: Good morning, and welcome to the ...

AngioDynamics, Inc. ( NASDAQ: ANGO) Q4 2025 Earnings Conference Call July 15, 2025 8:00 AM ET James C. Clemmer - CEO, President & Director Stephen A. Trowbridge - Executive VP & CFO ...

AngioDynamics Inc (ANGO) reports a robust 12% revenue increase, driven by Med Tech advancements, despite facing tariff impacts.

Gain insights into AngioDynamics' Q4 2025 earnings, highlighting 12% revenue growth, international expansion, Med Tech advances, and a strong FY26 outlook.

Analysts estimate that AngioDynamics will report an earnings per share (EPS) of $-0.12. Investors in AngioDynamics are eagerly awaiting the company's announcement, hoping for news of surpassing ...

Piccolo Medical, Inc. (Piccolo), a leading innovator in vascular access technology, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its next ...

Authorities at Tehran's Evin Prison were still attending to the dead and wounded on the evening of June 23 when one of the highest-profile inmates held there, Swedish-Iranian scientist Ahmadreza ...

S&P 500 E-Mini futures (ESU25) are up +0.39%, andSeptember Nasdaq 100 E-Mini futures (NQU25) are up +0.56% this morning as ...

Once a powerful watchdog for financial wrongdoing, the Consumer Financial Protection Bureau has seen its enforcement efforts ...

The Nasdaq Composite ended at 20,585.53, essentially flat on the week (–0.08%), holding just below recent record highs. The ...